US FDA expands use of J&J’s Caplyta as add-on depression drug - PharmaLive

Submitted by Anonymous (not verified) on Thu, 11/06/2025 - 13:54

US FDA expands use of J&J’s Caplyta as add-on depression drug  PharmaLive